Day: September 23, 2024

Hydro is pleased to invite investors, analysts, financial media and other stakeholders to its Capital Markets Day on November 27, 2024. The event will be held at the Royal Garden Hotel, 2-24 Kensington High Street, London W8 4PT, with the alternative of joining virtually. Please note that virtual attendees will not have the opportunity ask questions in the Q&A sessions or participate in 1:1 meeting.Agenda All times in GMT. Presentations and Q&A in “Palace Suite” 07:30: Registration and light breakfast 08:00: Presentation from CEO, Business Areas and CFO followed by Q&A sessions 11:30: Lunch 12:30 to 16:00: Investors and sell-side analysts are invited to meet with Hydro’s management teams. Please register your participation within November 6, by submitting this ‘Registration form.‘Virtual attendance: You...

RIM-TD open-label extension (OLE) study showed long-term improvement of Tardive Dyskinesia (TD) symptoms from treatment with deutetrabenazine over three years in European patients1TD is an involuntary movement disorder that develops in around 15%-25% of patients taking antipsychotic medications for conditions such as schizophrenia, bipolar disorder, and major depressive disorder2,3Data presented at the European College of Neuropsychopharmacology Congress (ECNP) in Milan 21-24 September 2024TEL AVIV, Israel, Sept. 23, 2024 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that a new analysis from the European cohort of the RIM-TD open-label extension (OLE) study revealed that deutetrabenazine treatment of patients with Tardive Dyskinesia (TD) was associated with long term improvement...

Roche’s CINtec PLUS Cytology is the only FDA-approved and CE-marked dual-stain test to triage human papillomavirus (HPV)-positive cervical cancer screening test results Dual-stain biomarkers aid in detection of cervical precancer and may reduce the number of women who undergo unnecessary colposcopy procedures while allowing earlier intervention for those who are at higher risk of developing cervical cancer. This recognition follows the American Society for Colposcopy and Cervical Pathology (ASCCP)’s recent inclusion of dual-stain testing in cervical cancer screening guidelines, as well as other WHO prequalifications of Roche’s cobas HPV testBasel, 23 September 2024 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the World Health Organization (WHO) has included dual-stain cytology testing in its cervical cancer prevention...

Press ReleaseNokia deploys high-performance cross-border DWDM network for IGCNokia’s Dense Wavelength Division Multiplexing (DWDM) solution was used by IGC to overlay and enhance the existing infrastructure to more effectively manage the growing capacity demand. The new, improved network allows IGC’s customers, including hyperscalers, to benefit from a high capacity, low latency and highly available network. Based on Nokia’s latest photonic service engine (PSE) chipset, Nokia’s DWDM solution will allow IGC to improve its energy efficiency while increasing network capacity and availability.23 September 2024Bangkok, Thailand – Nokia today announced that International Gateway Company Limited (IGC) has selected Nokia’s next-generation optical transport solution to modernize its existing DWDM network, which connects the East region to...